FIELD: medicine. SUBSTANCE: method involves covering solid body carrier having organ-specific antigens absorbed thereon with control serum and sera under study in working dilution of 1:100. Immunoenzyme analysis is carried out and optical density of the control serum and sera under study is measured to determine by difference between optical density of sample under study and negative control sample interpreted in terms of availability of antibodies to various organ-specific antigens. The value being equal to or greater than 0.2, active humoral immunity with respect to particular organ is considered to take place. EFFECT: high accuracy in determining immunity activity with respect to particular organ and in determining process propagation over a system of organs. 4 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DETERMINING HUMORAL IMMUNITY LEVEL WITH RESPECT TO CONDITIONALLY PATHOGENIC BACTERIA BY SIMULTANEOUSLY DETECTING IGG ANTIBODIES | 2002 |
|
RU2213972C1 |
METHOD OF POSTVACCINAL IMMUNITY TO VACCINE "PNEUMO-23" ANTIGENES TEST | 2006 |
|
RU2331074C2 |
METHOD OF ANTIBODIES TEST TO CAPSULAR POLYSACCHARIDE Haemophillus influenzae TYPE b | 2006 |
|
RU2331075C2 |
IMMUNE DIAGNOSTIC TECHNIQUE FOR DISEASES CAUSED BY HELICOBACTER PYLORI INFECTION | 2014 |
|
RU2572717C1 |
METHOD OF PREDICTING COURSE OF VIRAL ENCEPHALITIS | 2003 |
|
RU2235328C1 |
METHOD FOR OBTAINING SPECIFIC ANTIGENIC PREPARATIONS FROM CLINICALLY SIGNIFICANT YEAST FUNGI | 2015 |
|
RU2660365C1 |
METHOD FOR DIAGNOSIS OF AUTOIMMUNE LIVER INJURY IN PATIENT WITH CHRONIC HEPATITIS | 2003 |
|
RU2247387C1 |
HUMAN IMMUNODEFICIENCY VIRUS STRAIN TYPE 1 IV741 SUBTYPE AE FOR DIAGNOSTIC AND VACCINE PREPARATIONS | 2012 |
|
RU2520814C2 |
METHOD FOR QUANTITATIVE DETECTING CONCENTRATION OF ANTIBODIES SPECIFIC TO ANTIGENS OF HUMAN STEROID-PRODUCING CELLS IN HUMAN BIOLOGICAL LIQUIDS CONTAINING SPECIFIC ANTIBODIES | 2002 |
|
RU2216742C2 |
METHOD OF SERUM DIAGNOSTICS OF PERTUSSIS | 2009 |
|
RU2424530C1 |
Authors
Dates
2003-10-10—Published
2002-09-19—Filed